Commentary: Improving breast cancer testing for patients - The secret sauce is collaboration

Journal of Oncology Practice

Volumn 6, Issue 4, 2010, Pages 198-

  Hammond, M Elizabeth H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

BREAST CANCER; CANCER TEST; HORMONAL THERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; NOTE; PRACTICE GUIDELINE; QUALITY CONTROL;

EID: 78149325314     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.777012     Document Type: Note

References (4)

1. Hammond ME, Hayes DF, Dowsett M, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784-2795, 2010
2. Hammond MEH, Hayes, DF, Wolff AC, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract 6:195-197, 2010
3. Nkoy FL, Hammond ME, Rees W, et al: Variable specimen handling affects hormone receptor test results in women with breast cancer: A large multihospital retrospective study. Arch Path Lab Med 134:606-612, 2010
4. Nichols HB, Trentham-Dietz A, Love RR, et al: Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. Cancer Epidemiol Biomarkers Prev 14:41-47, 2005 (Pubitemid 40165281)